
    
      The investigators' hypothesis is that, multiple myeloma plasma cells derivate from principal
      cells that is called "cancer or progenitor stem cell". In multiple myeloma to define
      immunophenotyping features of these "cancer stem cells" with flow cytometry and to show their
      prognostic value and check for any relationship between cancer stem cell quantification and
      chemotherapy response are main aims of this study.
    
  